Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

Dunlay, Shannon M., Givertz, Michael M., Aguilar, David, Allen, Larry A., Chan, Michael, Desai, Akshay S., Deswal, Anita, Dickson, Victoria Vaughan +6 more·2019·Circulation
DOI 10.1161/cir.0000000000000691

Cited by (649)

Items 301–400 of 649

  1. Association of the KDIGO Risk Classification with the Prevalence of Heart Failure in Patients with Type 2 Diabetes
    José Antonio Gimeno-Orna, Luis Rodrı́guez Padial, Manuel P. Anguita-Sánchez, Vivencio Barrios, Javier Muñiz, Antonio Pérez · 2021 · Journal of Clinical Medicine
  2. Intersection Between Diabetes and Heart Failure: Is SGLT2i the “One Stone for Two Birds” Approach?
    Qing Zhang, Yu Kang, Siqi Tang, Cheuk-Man Yu · 2021 · Current Cardiology Reports
  3. Myeloid differential protein-2 inhibition improves diabetic cardiomyopathy via p38MAPK inhibition and AMPK pathway activation
    Jianchang Qian, Fei Zhuang, Yujing Chen, Xinrong Fan, Jun Wang, Zhe Wang, Yi Wang, Ming‐Jiang Xu, Александр Владимирович Самородов, В. Н. Павлов et al. · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  4. Foot self‐care behaviour in type 2 diabetes adults with and without comorbid heart failure
    Fekadu Aga, Sandra Barker Dunbar, Tedla Kebede, Senbeta Guteta Abdissa, Melinda Kay Higgins, REBECCA A. GARY · 2022 · Nursing Open
  5. New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine
    Francesco Giallauria, Roberto Baratta, Francesco Costa, Domenico D’Amario, Luisa De Gennaro, Simona Giubilato, Alessandro Mattina, Michele Provenzano, Domenico Santoro, Francesco Versaci · 2022 · Minerva Medica
  6. Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes
    Niki Katsiki, Kyriakos Kazakos, Filippos K. Triposkiadis · 2022 · Expert Opinion on Pharmacotherapy
  7. Prognostic Implications of Type 2 Diabetes Mellitus in Heart Failure with Mildly Reduced Ejection Fraction
    Tobias Schupp, Mohammad Abumayyaleh, Kathrin Weidner, Felix Lau, Marielen Reinhardt, Noah Abel, Alexander Schmitt, Jan Forner, Niklas Ayasse, Thomas Bertsch et al. · 2024 · Journal of Clinical Medicine
  8. Screening for heart failure in patients with diabetes mellitus in tertiary care – A SwissDiab study
    Laura Knaus, Marino Quarella, Marc Buser, Micha Tobias Maeder, Frida Renström, Michael Brändle · 2024 · Diabetes Research and Clinical Practice
  9. Roles of cMyBP-C phosphorylation on cardiac contractile dysfunction in db/db mice
    Darshini A. Desai, Akhil Baby, Kalyani Ananthamohan, Lisa C. Green, Mohammed Arif, Brittany C. Duncan, Mohit Kumar, Rohit R. Singh, Sheryl E. Koch, Sankar Natesan et al. · 2024 · Journal of Molecular and Cellular Cardiology Plus
  10. Non-cardiac comorbidities in heart failure: an update on diagnostic and management strategies
    Nandan Kodur, W.H. Wilson Tang · 2024 · Minerva Medica
  11. Sex differences in the diagnostic algorithm of screening for heart failure by symptoms and NT-proBNP in patients with type 2 diabetes
    Sarah Hofer-Zeni, Michael Leutner, Peter Klimek, Luise Bellach, Noémi Pávó, Suriya Prausmüller, Martin Hülsmann, Alexandra Kautzky‐Willer · 2024 · Cardiovascular Diabetology
  12. Prescription Fills Among Patients With Type 2 Diabetes After Hospitalization for Acute Coronary Syndrome
    Michelle D. Kelsey, Cassie B. Ford, Megan M. Oakes, Samir S. Soneji, Hayden Barry Bosworth, Neha Jadeja Pagidipati · 2024 · JAMA Network Open
  13. Diabetic ketoacidosis and hyperosmolar hyperglycemic state in diabetes patients with heart failure: insight from the National inpatient sample
    Hasan Alroobi, S. Dargham, Z. Mahfoud, Amin Jayyousi, J. Al Suwaidi, Charbel Abi Khalil · 2025 · BMC Cardiovascular Disorders
  14. Sociodemographic and clinical correlates of diabetes self‐efficacy in adults with type 2 diabetes and comorbid heart failure
    Fekadu Aga, Sandra Barker Dunbar, Tedla Kebede, Melinda Kay Higgins, REBECCA A. GARY · 2019 · Research in Nursing & Health
  15. Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adults with heart failure and diabetes
    Chintan V. Dave, Brian L. Strom, Fred A. Kobylarz, Daniel B. Horton, Tobias Gerhard, Chin‐Lin Tseng, Ilja Dejanovic, Abner N. Nyandege, Soko Setoguchi · 2021 · Pharmacoepidemiology and Drug Safety
  16. Relationship of Diabetes, Heart Failure, and N-Terminal Pro-B-Type Natriuretic Peptide with Cardiovascular Outcomes in Patients with Atrial Fibrillation
    Felix Hofer, Ulrike Pailer, Patrick Sulzgruber, Christian Gerges, Max‐Paul Winter, Robert Patrick Giugliano, Michael Gottsauner‐Wolf, Martin Hülsmann, Niema Kazem, Lorenz Koller et al. · 2022 · ESC Heart Failure
  17. Relationship Between Subclinical Cardiovascular Diseases and Cardiac Morpho-Functional Parameters in Preclinical Stage A/B Heart Failure Adults with Type 2 Diabetes
    Yan Xiao, Xinyue Yao, Yonghui Wang, Lanwen Han, Lianxia Li, Ming Li, Shan Gao · 2022 · Diabetes Metabolic Syndrome and Obesity
  18. Characteristics of women with type 2 diabetes and heart failure in Spain. The DIABET-IC study
    Luis Rodrı́guez Padial, Antonio Pérez, Manuel Anguita Sánchez, Vivencio Barrios, Jose Antonio Gimeno-Orna, Javier Muñiz · 2023 · Cardiology Journal
  19. Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
    Shu Ning Lin, Kok Kit Phang, Seng Hsiung Toh, Kok Han Chee, Hasniza Zaman Huri · 2020 · Frontiers in Endocrinology
  20. SGLT-2 Inhibitor Use in Heart Failure
    Katherine L. March, Jack G. Lukas, Theodore J. Berei, Samarth P. Shah, Brandon E. Cave · 2022 · Critical Care Nursing Quarterly
  21. The Early Prediction of Patient Outcomes in Acute Heart Failure: A Retrospective Study
    Maria Boesing, Justas Grimalauskas‐Suchina, Giorgia Lüthi-Corridori, Fabienne Jaun, Michael Brändle, Jörg D. Leuppi · 2025 · Journal of Cardiovascular Development and Disease
  22. GLP-1 receptor agonists and clinical outcomes in patients with type 2 diabetes undergoing transcatheter aortic valve implantation
    Hoang Nhat Pham, Ramzi Ibrahim, Mahmoud Hassan Abdelnabi, George Bcharah, Ahmed Mahmoud, Mohamed Allam, Juan Farina, Justin Z. Lee, Amitoj Singh, Chadi Ayoub et al. · 2025 · European Heart Journal - Quality of Care and Clinical Outcomes
  23. Synergistic effects of hypertension and diabetes on cardiovascular risk in elderly: Comparative longitudinal analysis of CHARLS and HRS
    Qiang Su, Wan-Zhong Huang, Yuan Huang, Li-Rong Mo, Jian-He Lin, Zhongxin Qin · 2026 · Diabetes, obesity and metabolism
  24. High Variability of Body Mass Index Is Independently Associated With Incident Heart Failure
    Chang Liu, Yiyun Chiang, Qin Hui, Jin J. Zhou, Peter W.F. Wilson, Jacob Joseph, Yan V. Sun · 2024 · Journal of the American Heart Association
  25. Effect of the use of dapagliflozin in diuresis, natriuriesis, and in ultrafiltration and peritoneal elimination of sodium in patients with refractory heart failure: DAPA-DP study
    Marco Montomoli, Camila Solano Rivera, Miguel González Rico, Rafael de la Espriella Juan, Gonzalo Nuñez Marín, María Jesús Puchades Montesa, José Luis Teruel · 2024 · Renal Replacement Therapy
  26. Association of Different Types of Diabetic Autonomic Neuropathy With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes: A Cross‐Sectional Study
    Ruixue Feng, Donge Yan, Mingxin Bai, Xingwu Ran, Dawei Chen, Chun Wang, Lihong Chen, Shuang Lin, Sen He, Yan Liu et al. · 2025 · Journal of Diabetes
  27. Impact of type 2 diabetes on life expectancy and role of kidney disease among inpatients with heart failure in Switzerland: an ambispective cohort study
    Dante Salvador, Arjola Bano, Faina Wehrli, Valentina González-Jaramillo, Markus Wolfgang Laimer, Lukas Hunziker, Taulant Muka · 2023 · Cardiovascular Diabetology
  28. Triglyceride glucose index: a significant prognostic marker of heart failure in patients with chronic kidney disease
    Shijie Liu, Xuefu Chen, Qian Guo, Jingwen Dou, Jiaxin Huang, Lewen Jia · 2024 · Renal Failure
  29. Exploring Mortality and Prognostic Factors of Heart Failure with In-Hospital and Emergency Patients by Electronic Medical Records: A Machine Learning Approach
    Cheng-Sheng Yu, Jenny L Wu, Chun‐Ming Shih, Kuan-Lin Chiu, Yu-Da Chen, Tzu‐Hao Chang · 2025 · Risk Management and Healthcare Policy
  30. Inhibition of the Renin–Angiotensin System Improves Hemodynamic Function of the Diabetic Rat Heart by Restoring Intracellular Calcium Regulation
    Krisztina Anna Paulik, Tamás Ivanics, Gábor Artúr Dunay, Ágnes Fülöp, Margit Kerék, Klára Takács, Zoltán Benyó, Zsuzsanna Miklós · 2025 · Biomedicines
  31. “Is sotagliflozin a ‘wonder drug’? A review of its impact on cardiovascular, diabetic, renal, neuroprotective, and hepatic outcomes”
    Eeshal Fatima, Hamza Irfan, Faiza Fatima, Jyoti Jain, Obaid Ur Rehman, Ayesha Sehar, Bilal Ahmad, Sanjana Kumari, Aymar Akilimali · 2025 · Annals of Medicine and Surgery
  32. Measures of Left Ventricular Diastolic Function and Cardiorespiratory Fitness According to Glucose Metabolism Status: The Maastricht Study
    Marja G. J. Veugen, Pauline B. C. Linssen, Ronald M.A. Henry, Annemarie Koster, Abraham A. Kroon, Coen D.A. Stehouwer, Hans‐Peter Brunner‐La Rocca · 2021 · Journal of the American Heart Association
  33. Outcomes of patients with atrial fibrillation with and without diabetes: A propensity score matching of the COOL‐AF registry
    Rungroj Krittayaphong, Suchart Aroonsiriwattana, Pornchai Ngamjanyaporn, Thanasak Patmuk, Pontawee Kaewkumdee, for the COOL‐AF Investigators · 2021 · International Journal of Clinical Practice
  34. Outcomes of diabetic patients with end‐stage heart failure listed for heart transplantation: A propensity‐matched analysis
    Emmanuel O. Akintoye, Paulino Antonio Alvarez, Mohamed Salih, Frank William Sellke, Αlexandros Briasoulis · 2022 · Clinical Transplantation
  35. To Evaluate the ‘Real World’ Clinical Performance of Bisoprolol in Post-Myocardial Infarction with Left-Ventricular Dysfunction: TENACITY Study
    Kamal H. Sharma · 2022 · Cardiology Research and Cardiovascular Medicine
  36. Hyponatremia Is a Powerful Predictor of Poor Prognosis in Left Ventricular Assist Device Patients
    Anjan Tibrewala, Ramsey M. Wehbe, Tingqing Wu, Rebecca Harap, Kambiz Ghafourian, Jane E. Wilcox, Ike Stanley Okwuosa, Esther Vorovich, Faraz S. Ahmad, Clyde W. Yancy et al. · 2022 · ASAIO Journal
  37. Effects of the Sodium-Glucose Cotransporter Inhibitors on Cardiovascular Death and All-Cause Mortality: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Clinical Trials
    Nathaniel E. Eraikhuemen, Simon Leung, Shalonda Barnes Warren, Dovena Lazaridis, Carla Hawkins Smith, Margaretta L. Kearson, Valerie Marcellus · 2022 · American Journal of Cardiovascular Drugs
  38. In search of mechanisms to explain the unquestionable benefit derived from sodium-glucose cotransporter-2 (SGLT-2) inhibitors use in heart failure patients
    Angel López‐Candales, Khalid Sawalha, Betty M. Drees, Nicholas B. Norgard · 2023 · Postgraduate Medicine
  39. Fat Mass is Associated with Subclinical Left Ventricular Systolic Dysfunction in Patients with Type 2 Diabetes Mellitus Without Established Cardiovascular Diseases
    Jie Liu, Fan Yang, Qichao Sun, Tianwei Gu, Jing Yao, Ning Zhang, Ran Meng, Dalong Zhu · 2023 · Diabetes Therapy
  40. Association Between Serum 3-Hydroxyisobutyric Acid and Prognosis in Patients With Chronic Heart Failure ― An Analysis of the KUNIUMI Registry Chronic Cohort ―
    Wataru Fujimoto, Manabu Nagao, Makoto Nishimori, Masakazu Shinohara, Makoto Takemoto, Koji Kuroda, Soichiro Yamashita, Junichi Imanishi, Masamichi Iwasaki, Takafumi Todoroki et al. · 2023 · Circulation Journal
  41. Association between serum chloride and in-hospital mortality in congestive heart failure with diabetes: Data from the MIMIC-IV database
    Kai Zhang, Yu Han, Fangming Gu, Zhaoxuan Gu, Jiayu Zhao, Jianguo Chen, Bowen Chen, Min Gao, Zhengyan Hou, Xiaoqi Yu et al. · 2023 · Journal of Diabetes & Metabolic Disorders
  42. Prognostic Implications of Insulin Resistance in Heart Failure in Japan
    Keiichiro Iwasaki, Kazufumi Nakamura, Satoshi Akagi, Yoichi Takaya, Hironobu Toda, Toru Miyoshi, Shinsuke Yuasa · 2024 · Nutrients
  43. Relationship of plasma aldosterone levels and carbohydrate metabolism in heart failure with preserved ejection fraction
    A. N. Shevelok · 2021 · Russian Journal of Cardiology
  44. Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects
    Ashit Trivedi, Rajneet K. Oberoi, Pegah Jafarinasabian, Hanze Zhang, Marintan Spring, Stephen D. Flach, Siddique A. Abbasi, Sandeep Dutta, Edward Wolfgang Lee · 2021 · Clinical Drug Investigation
  45. Healthcare disparities in heart failure patients (with and without type 2 diabetes) and use of sodium glucose co-transport inhibitors (SGLT2-i)
    Shivank Madan, Muhammad Farooq, Karim Assaad Diab, Angelos Arfaras-Melainis, Katherine E. Di Palo, Jill P. Crandall, Carlos J. Rodríguez, Ulrich P. Jorde · 2021 · Endocrine
  46. Periodic study of electrocardiogram abnormalities can predict major adverse cardiac events in Type 2 diabetics
    Sarbashri Bank, Madhusudan Das · 2023 · European Journal of Preventive Cardiology
  47. Comment on: Perceived heart attack likelihood in adults with a high diabetes risk
    Rabia Islam, Hamza Islam · 2023 · Heart & Lung
  48. FGF9 alleviates diabetic cardiomyopathy by activating Nrf2 via SQSTM1/p62-Keap1 in mice
    Ning An, Yunjie Chen, Lin Li, Bingyu Wang, Xuan Zhou, Gen Chen · 2025 · Communications Biology
  49. From guidelines to practice: an Egyptian expert opinion on type 2 diabetes mellitus management in primary care settings
    Mohamed A. Khattab, Samir Helmy Assaad Khalil, Atef Bassyouni, Farid Fawzy, Abdelrahman Hesham Elgayar, Ibrahim Elebrashy, Khaled Elsayed Elhadidy, Khalifa Abdallah, Mohamed H. El-Hefnawy, Mohamed Reda Halawa et al. · 2025 · BMC Family Practice
  50. Molecular Mechanisms and Multi-Omics Integration in Heart Failure: From Pathophysiology to Precision Medicine
    Carlo Domenico Maida, Gaetano Pacinella, Mario Daidone, Mariarita Margherita Bona, Stefania Scaglione, Rachele Malfitano, Rosario Luca Norrito, Giuliano Cassataro, Luigi Dell’Ajra, Sergio Ferrantelli et al. · 2026 · International Journal of Molecular Sciences
  51. AMPK Signalling in Heart Failure: From Metabolic Sensor to Context-Dependent Therapeutic Target
    Rayan Arzouni, Reem F. M. Aazar, Seif Asakrieh, Seif Cattan, Aleksandar Jovanović · 2026 · Biomedicines
  52. Effect of fenofibrate on blood lipid, sICAM-1, ET-1 and prognosis in chronic heart failure patients complicated with diabetes
    Xiuli Liu, Jifeng Zhang, Wenzong Zhou, J Liu, Yingli Wang · 2023 · Cellular and Molecular Biology
  53. Association of insulin use with LV remodeling and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: assessed by cardiac MRI
    Ke Shi, Ge Zhang, Hang Fu, Shan Huang, Huayan Xu, Yue Gao, Rui Shi, Wei‐Feng Yan, Wen‐Lei Qian, Yuan Li et al. · 2023 · Cardiovascular Diabetology
  54. Differences in the impact of newly diagnosed type 2 diabetes on cardiovascular mortality between normotensive and hypertensive individuals
    N. Sasaki, R. Maeda, R. Ozono, Kenichi Yoshimura, Y. Nakano, Yukihito Higashi · 2024 · Journal of Hypertension
  55. Temporal Trends in the Initiation of Dialysis Among Patients With Heart Failure With or Without Diabetes: A Nationwide Study From 2002 to 2016
    Pauline Knigge, Sørine Lundberg, Jarl Emanuel Strange, Mariam Elmegaard Malik, Nina Nouhravesh, A K Wagner, Gunnar Gislason, Emil Loldrup Fosbøl, Nicholas Carlson, Deewa Zahir et al. · 2024 · Journal of the American Heart Association
  56. Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
    Allan Zhang, Ramsey K. Kalil, Alexander Marzec, Stephanie Coulter, Salim S. Virani, Kershaw V. Patel, Matthew W. Segar · 2024 · Texas Heart Institute Journal
  57. Cadmium and selenium blood levels in association with congestive heart failure in diabetic and prediabetic patients: a cross-sectional study from the national health and nutrition examination survey
    Renyue Ji, Haisheng Wu, Hongli Lin, Li Yang, Yumeng Shi · 2025 · Diabetology & Metabolic Syndrome
  58. Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery
    Ashley C. Wang, Savannah Bitzas, Dilsa Perez, Jonathon A. Schwartz, Saleem Zaidi, Jonathan Oster, Sergio Daniel Bergese · 2025 · Life
  59. SGLT2 inhibitors are associated with a reduced incidence of atrial fibrillation in type 2 diabetes mellitus
    Mark Lüdde, Jamschid Sedighi, Hans‐Joerg Hippe, Samuel Tobias Sossalla, Karel Kostev · 2025 · Diabetes Obesity and Metabolism
  60. Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure
    Dana Darwish, Pooja Kumar, Khushi Urs, Siddharth Dave · 2025 · Cells
  61. Budget Impact Analysis of Pharmacist-Led Medication Management in Cardiovascular and Type 2 Diabetic Patients
    Iva Mucalo, Andrea Brajković, Marija Strgačić, Djenane Ramalho de Oliveira, Elizabeta Ribarić, Ana Bobinac · 2022 · Healthcare
  62. Development of Prediction Model to Estimate the Risk of Heart Failure in Diabetes Mellitus
    Hongling Qu, Cuiyun Wu, Peijie Ye, Weibiao Lv · 2022 · Frontiers in Cardiovascular Medicine
  63. Documento de consenso sobre el manejo de la diabetes tipo 2 y la insuficiencia cardíaca: Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH) de la Sociedad Interamericana de Cardiología (SIAC)
    Alexander Romero, Clara Saldarriaga, Carlos E. Ramos, Daniel Quesada, Gerardo Chazzin, Felipe Nery Gervacio Fernández, Freddy Pow-Chon-Long, Walter Alarco, Pablo E. Hurtado, José Antonio Magaña et al. · 2023 · Archivos de cardiología de México
  64. Role of Liraglutide Use in Patients With Heart Failure
    Sanjana Reddy Allam, Sahil Sartaj, Hiba Moquim, Muhammad Ammar Husnain, Daniel Bustos, Mohit Lakkimsetti, Avneet K Randhawa, Ishita Gupta · 2023 · Cureus
  65. Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status
    Xin Yi Xu, Q W Ren, Chanchal Chandramouli, Ming‐Yen Ng, Christopher Tze‐Wei Tsang, Yi‐Kei Tse, Xinli Li, Mingya Liu, Mei‐Zhen Wu, Jiayi Huang et al. · 2024 · Journal of the American Heart Association
  66. Application of neutrophil-lymphocyte ratio and red blood cell distribution width in diabetes mellitus complicated with heart failure
    Jie Pang, Lin-Yan Qian, Ping Lv, Xiao-ru Che · 2024 · World Journal of Diabetes
  67. Pharmacological Treatment of Diabetes Mellitus: An Overview of New Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Diabetes Mellitus
    Mateusz Nieczyporuk, Paweł Tyrna, Tomasz Cader, Aleksandra Sikora, Szymon Staneta · 2024 · Journal of Endocrinology and Metabolism
  68. Ninerafaxstat in the Treatment of Diabetic Cardiomyopathy and Nonobstructive Hypertrophic Cardiomyopathy
    Jared M. Feldman, William H. Frishman, Wilbert S. Aronow · 2024 · Cardiology in Review
  69. Emirates consensus recommendations on cardiovascular risk management in type 2 diabetes
    Hani Mohamed Sabbour, Wael A. Almahmeed, Fatheya Alawadi, Abdullah Mohammed Shehab, Abdulamjeed Al Zubaidi, Alaaeldin M. Bashier, Abdul Rauf Ghulam, Fouzia Rashid, Hosam Zaky, Hussien Heshmat Kassem et al. · 2025 · Frontiers in Endocrinology
  70. Adeno-Associated Viruses as Gene Delivery Tools for Diabetic Heart Disease and Failure: Key Considerations for Clinicians and Preclinical Researchers
    Kate L. Weeks, Bianca C. Bernardo · 2025 · Heart Lung and Circulation
  71. Twelve‐year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States
    Ghadeer K. Dawwas, Charles E. Leonard, Mahek Garg, Scott Martin Vouri, Steven M. Smith, James Flory, Michael V. Genuardi, Haesuk Park · 2020 · Diabetes Obesity and Metabolism
  72. Comparing the Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists with Sodium-Glucose Cotransporter 2 Inhibitors for Obese Type 2 Diabetes Patients Uncontrolled on Metformin: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Lu Ding, Bang Sun, Xinhua Xiao, Tatsuya Kin · 2020 · International Journal of Endocrinology
  73. Type 2 diabetes mellitus and cardiovascular disease: focus on the effect of antihyperglycemic treatments on cardiovascular outcomes
    Ravi Choxi, Sumon Roy, Angeliki M. Stamatouli, Stephanie Mayer, Ion S. Jovin · 2020 · Expert Review of Cardiovascular Therapy
  74. Self-Care Behavior in Heart Failure Patients: Impact on Cardiovascular Health Profile
    Dwi Prihatiningsih, Widaryati Widaryati · 2021 · Jurnal Keperawatan
  75. Metabolic Reprogramming in Congenital Cyanotic Heart Disease: Another Fight in Puberty?
    Natascha Sommer, Norbert Weißmann, Hossein Ardeschir Ghofrani · 2021 · Circulation
  76. Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions
    Gary Michael Felker, Peter M. Buttrick, Anthony Rosenzweig, E. Dale Abel, Larry A. Allen, Michael R. Bristow, Saumya Das, Adam D. DeVore, Stavros George Drakos, James Chen-Tson Fang et al. · 2022 · Journal of the American Heart Association
  77. Risk Factors Association with Transcriptional Activity of Metalloproteinase 9 (MMP-9) and Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) Genes in Patients with Heart Failure
    Józefa Dąbek, Dariusz Korzeń, Oskar Sierka, Lech Paluszkiewicz, Hendrik Milting, Zbigniew Gąsior · 2024 · Biomedicines
  78. Methylophiopogonanone A alleviates diabetic cardiomyopathy via inhibiting JNK1 signaling
    Jing Yin, Zhicheng Song, Lijun Zhang, Jialin Cong · 2025 · Cellular Signalling
  79. Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide
    Larissa Dăniluc, Adina Braha, Oana Elena Sandu, Carina Bogdan, Loredana Suhov, Lina Haj Ali, Alexandra-Iulia Lazăr-Höcher, Alexandra Christa Sima, Adrian Apostol, Viviana Mihaela Ivan · 2025 · Medicina
  80. Comparison of Waist Circumference in Type 2 Diabetes and Non - Diabetic Population
    Latha Sannasi · 2025 · Global Journal of Medical Pharmaceutical and Biomedical Update
  81. The effects of initiating a 24-hour fast with a low versus a high carbohydrate shake on glycemic control in older adults: a randomized crossover study
    Elizabeth Z. Gipson, Landon S. Deru, Parker G Graves, Cameron G Jacobsen, Neil E. Peterson, Bruce Wayne Bailey · 2025 · Nutrition & Metabolism
  82. Comorbid cardiovascular diseases and predictors among adults with type 2 diabetes in Bahir Dar city, Ethiopia: a multicentre hospital-based cross-sectional study
    Zemenu Addis, Alemeshet Yirga Berhie, Teshager Woldegiorgis Abate, Bekalu Mekonen Belay, Habtam Wale, Ayenew Tega, Tamiru Alene · 2025 · BMJ Open
  83. Clinical risk phenotypes in diabetes and their associations with adverse cardiovascular events: A report from the Silesia Diabetes‐Heart Project
    Marta Mantovani, Hanna Kwiendacz, Krzysztof Irlik, Tommaso Bucci, Mirela Hendel, Steven Ho Man Lam, Bi Huang, Paulina Szromek‐Białek, Monika Niezgoda, Uazman Alam et al. · 2025 · Diabetic Medicine
  84. Association between triglyceride glucose-body mass index and long-term adverse outcomes in individuals with heart failure: a retrospective cohort study
    Yanan Shi, Chuanyu Gao, Yu Xu, Fang Yuan · 2025 · Frontiers in Nutrition
  85. Efficacy and safety of GLP-1 receptor agonists in the treatment of type 2 diabetes and/or obesity in patients with Cushing’s syndrome: a multicenter retrospective study
    Pedro Iglesias, Ema Lacerda Nobre, Felicia Alexandra Hanzu, Júnia Ribeiro de Oliveira Longo Schweizer, Lucía Manzano Valero, Marta Araujo-Castro, Ana Castro Luna, Francisco Javier Albacete, Rocío Villar‐Taibo, Martin Reinke · 2026 · Endocrine
  86. Diastolic dysfunction is equally common in pre-diabetes and diabetes and associated with concomitant cardiometabolic risk factors
    David Kylhammar, Lina Hult, Peter Blomstrand, Hannes Holm Isholth, Amra Jujić, Martin Magnusson, Carl Johan Östgren, Jan Edvin Engvall, Kristofer Hedman · 2026 · Open Heart
  87. Neutrophil Extracellular Traps in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Targets
    Shengbo Ye, Zhengwei Dong, Xiaorui Jiang, X Li, Xinlu Wang, Bin Li, Rui Yu, Genhao Fan, Yongxia Wang, Mingjun Zhu et al. · 2026 · Journal of Inflammation Research
  88. Analysis of Circulating Long Non‐Coding RNA in Prediabetes or Newly Diagnosed Type 2 Diabetes Subjects With or Without Heart Stress
    Francesco Di Giacomo Barbagallo, Giosiana Bosco, Lorena Lanzafame, Maurizio Di Marco, Sabrina Scilletta, Luisa Spadaro, Giulia Crisci, Mariarosaria De Luca, Ernestina Marianna De Francesco, Roberta Malaguarnera et al. · 2026 · Diabetes/Metabolism Research and Reviews
  89. Impact of diabetic retinopathy on prognosis of patients with heart failure with preserved ejection fraction
    Yaping Yang, Yue Zhou, Yu Cao, Yugang Dong, Chao Liu, Wengen Zhu · 2022 · Nutrition Metabolism and Cardiovascular Diseases
  90. Missed Opportunities for Screening and Management of Dysglycemia among Patients Presenting with Acute Myocardial Infarction in North India: The Prospective NORIN STEMI Registry
    John W. Ostrominski, Muthiah Vaduganathan, Meennahalli Palleda Girish, Puneet Kumar Gupta, Michael J. Hendrickson, Arman Qamar, Sameer Arora, Ambarish Pandey, Ankit Bansal, Vishal Batra et al. · 2022 · Global Heart
  91. Effect of arotinolol on chronic heart failure: A systematic review and meta-analysis of randomized controlled trials
    Pingping Huang, Qing-zhen Song, Yifei Wang, Anzhu Wang, Li-Jun Guo, Hong-Wei Zhang, Zhi-Bo Zhang, Xiaochang Ma · 2022 · Frontiers in Cardiovascular Medicine
  92. Using the IMEDS distributed database for epidemiological studies in type 2 diabetes mellitus
    TING-YING JANE HUANG, Carla Rodriguez‐Watson, Tongtong Wang, Shawna R. Calhoun, James H. Marshall, Jillian Burk, Young Hee Nam, Aaron B. Mendelsohn, Aziza Jamal‐Allial, Robert T. Greenlee et al. · 2022 · BMJ Open Diabetes Research & Care
  93. Two-Year Changes in Diabetic Kidney Disease Phenotype and the Risk of Heart Failure: A Nationwide Population-Based Study in Korea
    Seung Eun Lee, Juhwan Yoo, Han Seok Choi, Kyungdo Han, Kyoung‐Ah Kim · 2023 · Diabetes & Metabolism Journal
  94. Renin-Angiotensin-Aldosterone System in Diabetic Cardiovascular Complications
    Vaidyanathapuram S. Balakrishnan · 2023 · Contemporary cardiology
  95. Use of Diabetes Medications before and after a Heart Failure–Related Hospitalization among Nursing Home Residents
    Tingting Zhang, Andrew R. Zullo, Kaleen N. Hayes, Dae Hyun Kim, Yoojin Lee, Lori A. Daiello, Douglas P. Kiel, Sarah D. Berry · 2023 · Journal of the American Medical Directors Association
  96. Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF
    Abhinav Sharma, Daniel Caldeira, Amir Razaghizad, Fausto José Pinto, Dirk Jan van Veldhuisen, Mandeep R. Mehra, Carolyn S.P. Lam, John G.F. Cleland, Stefan D. Anker, Barry Greenberg et al. · 2023 · BMJ Open
  97. Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk
    Wanwarang Wongcharoen, Nichanan Osataphan, Siriluck Gunaparn, Suphot Srimahachota, Pornwalee Porapakkham, Somchai Dutsadeevettakul, Arintaya Phrommintikul · 2023 · Scientific Reports
  98. Effect of short-term cardiac function changes after cardiac resynchronization therapy on long-term prognosis in heart failure patients with and without diabetes
    Yu Yu, Ligang Ding, Hao Huang, Sijing Cheng, Yu Deng, Chi Cai, Min Gu, Xuhua Chen, Hongxia Niu, Wei Hua · 2024 · Therapeutic Advances in Chronic Disease
  99. The Impact of Diabetes on Haemodynamic and Cardiometabolic Responses in Heart Failure With Preserved Ejection Fraction
    Emilia Nan Tie, Shane Nanayakkara, Donna Vizi, Justin A. Mariani, David M. Kaye · 2024 · Heart Lung and Circulation
  100. Methods to predict heart failure in diabetes patients
    Alexander Е. Berezin, Tetiana A. Berezina, Uta Charlotte Hoppe, Michael Lichtenauer, Alexander A. Berezin · 2024 · Expert Review of Endocrinology & Metabolism